D.C. Circuit Affirms Rejection Of Section 340B Enforcement Letters

(May 24, 2024, 3:11 PM EDT) -- WASHINGTON, D.C. — Two drug manufacturers’ restrictions on the number of pharmacies they will service under the Section 340B drug price program of the Public Health Service Act do not run afoul of the program’s requirement that manufacturers offer drugs at or below the program’s price ceiling, a panel of the District of Columbia Circuit U.S. Court of Appeals said....

Attached Documents

Related Sections